UPDATE: BofA Securities Downgrades Rhythm Pharmaceuticals (RYTM) to Underperform
Tweet Send to a Friend
(Updated - August 4, 2021 6:52 AM EDT)
BofA Securities analyst Tazeen Ahmad downgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad downgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
